Background: The Depression, Anxiety, and Positive Outlook Scale (DAPOS) was designed to measure mood in pain populations without contamination from somatic items.
A nxiety and depression have been extensively researched in relation to pain, and often constitute part of outcome measures in psychologically based treatment. The relationship between pain and depression has been conceptually reviewed, [1] [2] [3] and examined in relation to prognosis. 4, 5 Research on anxiety includes theoretical and empirical studies on fear of pain 6 and on anxiety sensitivity, 7 whereas health anxiety has been used to conceptualize hypochondriasis. 8 There is an agreement that the concepts of distress, fear, depression, and anxiety are important, but there is also an acknowledged difficulty in accurate and appropriate measurement of negative mood in pain patients.
In a previous study, we developed a reliable and brief tool to assess mood in patients with chronic pain. 9 Nonsomatic items concerning depression, anxiety, and positive outlook were extracted using exploratory factor analysis from commonly used instruments (The Beck Depression Inventory 10 and the Hospital Anxiety and Depression Scale 11 ) and were completed by 940 chronic pain patients. Confirmatory factor analysis was used to test the internal structure of the final item set. Items were then reworded and presented as a new questionnaire [the Depression, Anxiety, and Positive Outlook Scale (DAPOS)] to 2 new samples: patients attending a pain management program and patients attending a large osteopathic teaching clinic. The new questionnaire was compared with several well-known questionnaires, including the SF-36 12 ; the Pain Catastrophizing Scale (PCS) 13 ; and the Beck Depression Inventory. 10 The structure of the DAPOS was tested using confirmatory factor analysis on both samples. Finally, a subset of patients carried out a sorting task to test for face validity. The DAPOS performed well on the goodness of fit indicators, 9 demonstrating that it is a reliable measure of the 3 mood states with good initial evidence of validity in pain patients. The DAPOS has yet to be tested in relation to clinical factors, using prospective designs. The aim of the current study was to continue to develop the questionnaire, by testing responsiveness and construct validity in patients with chronic pain before and after a multidisciplinary intervention.
METHODS

Design
This is a population-based, observational, validation study. a pain management clinic in the United Kingdom. The inclusion criteria were as follows: (1) troublesome, localized, or generalized pain that has affected individuals for more than half the days in the previous 12 months 14 ;
(2) completion of the requisite instruments without difficulty; and (3) at least 18 years of age. The exclusion criteria were as follows: (1) evidence of comorbid psychiatric diagnosis; (2) severe structural deformity, inflammatory diseases, vertebral fractures; or (3) pain associated with cancer. Only 1 participant was excluded on these grounds.
Procedure
Data were routinely collected as part of the assessment from all patients before and after the pain management program. All measures were taken 1 week before attending the program and for a subgroup of patients also on the last day of program. Patients attended 12 days of treatment over 4 weeks in a cognitive-behavioral multidisciplinary pain management program. Sessions were delivered by an interdisciplinary team: pain specialist, psychologist, physiotherapist, occupational therapist, and pain management nurse. The intervention focused on rehabilitation, defined as return to normal function and work. The content emphasized graded exercise program, instruction in pacing techniques, education about pain and its effects, and relaxation training.
All participants provided information about demographics and pain-related information (sex, age, education, marital status, work status, pain duration, pain severity, and pain location). All measures were completed in the presence of a clinician, and participants were encouraged to ask the clinician if they experienced any difficulties in completing the questionnaires. All patients were informed that measures would be used for research purposes. The response rate was 100%, as the questionnaires used for this study were an essential part of the standard assessment battery used by the pain management clinic, but some missing items in the questionnaires meant that they could not be included in the confirmatory factor analysis. All participants provided informed consent. Ethical approval was obtained by the College Ethical Committee.
A total of 243 patients meeting the inclusion criteria were included into the study. These patients completed the measures before the treatment. This sample was used to perform a confirmatory factor analysis. A subgroup of these patients (N = 82) also completed the measures on the last day of the course. The data collection for this time point was only instituted shortly before the study, so this subsample reflects changes in data collection, rather than any purposeful or random sampling. This second sample was used to calculate responsiveness, internal consistency, and to test the construct validity.
Measurements
Several measurements were collected from patients: 1. The DAPOS 9 contains 3 subscales: Depression, Anxiety, and Positive Outlook. Each of these provides an independent score and there is no total score. The possible range for the subscales is 5 to 25 for depression, 3 to 15 for anxiety, and 3 to 15 for positive outlook. Currently, there is no cutoff point for proposed ''caseness'' at a clinical level for any of the DAPOS subscales. 2. The SF-36 15 is a multipurpose generic health survey, which yields 8 scales of functional health and wellbeing. It has been extensively tested and is internationally used as an outcome measure. 15 
The Zung Depression Inventory (Zung) 16,17 has 23
items and a range of 0 to 69. It includes items about affect, cognitive impairment, and somatic symptoms. Cutoff points for ''at risk'' in pain populations are 17 to 33, and above 33 is considered depressive. 18 Because the inclusion of the somatic items (eg, ''I have trouble getting to sleep'' or ''I find it easy to do things I used to'') might reflect pain and disability rather than negative affect, analysis was carried out twice: on the Zung total score (23 items), and on the total score with somatic items excluded (10 items remaining). 4. The PCS 13 was designed to measure pain-related catastrophic thinking and was used in this study to compare with anxiety on the DAPOS. It consists of 13 items that are rated on a 5-point scale, ranging from 0 (not at all) to 4 (all the time). The range of possible scores is 0 to 52. 5. In addition, patients completed the following questionnaires: Roland and Morris Disability Questionnaire. 19 The Tampa Scale of Kinesiophobia. 20 Pain Self Efficacy Questionnaire (PSEQ). 21 Patients were also examined for physical measures, including their ability to walk, stand, and climb stairs. 22 
Clinimetric and Psychometric Testing
Sensitivity to change, also described as responsiveness, is the ability to detect important change over time in the concept being measured. Adequate measures of responsiveness include indicators of effect size (ES). We used a modified ES statistic proposed by Guyatt and colleagues. 23 Use of this allows ES comparisons across measures.
Construct validity, the extent to which scores on the questionnaire relate to other measures in a manner that is consistent with theoretically driven hypotheses, was measured by relating scores on subscales of the DAPOS to: (1) theoretically selected subscales on a generic health and well-being measure (SF-36 15 ) and (2) to other measurements, including depression (Zung 16 ) and catastrophizing (PCS 13 ). Specifically, we hypothesized a priori that there will be significant relationships between the DAPOS-D, the Zung, and the SF-36 Mental Health; the DAPOS-A with the SF-36 Mental Health and the PCS, the DAPOS-PO, and the SF-36 Vitality. The rational for the selection of the measures used, was primarily their theoretical foundation and the comparability of the results with the initial development study. 9 
Internal Consistency
The internal consistency was measured on the 3 subscales of the DAPOS using the Cronbach a, which indicates the extent to which a set of test items can be treated as measuring a single latent variable. Values of Cronbach a>0.7 were considered adequate. 24, 25 
Confirmatory Factor Analysis
To replicate the results on the internal structure and goodness of fit compared with the subscales previously defined, 9 a confirmatory factor analysis was performed using the analysis of moment structures (AMOS, version 4 26 ) statistical software package. In this confirmatory factor analysis, the data were treated as continuous and the goodness of fit was evaluated using the root mean square error of approximation (RMSEA), comparative fit index (CFI), goodness of fit index (GFI), and the adjusted goodness of fit index (AGFI). Multiple indices were used, because they provide different information about the model fit and when used together these indices provide a more conservative and reliable evaluation of the model solution. 27 An acceptable model fit was defined according to Bollen and Long's 28 criteria as follows: RMSEA (<0.08), CFI (>0.9), GFI (>0.9), and AGFI (>0.8).
Sample Size Considerations
For the purposes of the confirmatory factor analysis, a sample of 200 is considered acceptable. 24 The sample size for calculating responsiveness reflects the minimal acceptable ES at 0.4, which requires a minimum sample size of 54 paired observations. Our data set included 82 complete pairs. Table 1 provides a full description of the total sample (N = 243). The mean age of patients was 43.6 years (SD = 12.01) and ranged between 20 and 79 years. The sample consisted of 133 females and 110 males. The majority of patients were married (63.8%), without educational qualifications (37%) and employed full time (39.9%). The reported mean duration of pain was 65.3 months (SD = 76.50). The majority of patients reported low back pain (78.2). The remaining patients reported different pain sites such as shoulders/hands/arms (5.8), head/face (4.9%), neck (4.5%), and other pain locations (5.3%).
RESULTS
Additional t tests showed that there were no group differences in age or pain duration between the total sample and the subgroup (all Ps>0.15). w 2 analyses showed no differences between total group and subgroup on sex, education, marital, and work status (all Ps>0.20). Means, range of scores, and standard deviations for all measures pretreatment and posttreatment for the subgroup of 82 patients are presented in Table 2 .
Responsiveness
To calculate responsiveness (in the absence of a defined clinically important difference), we calculated the ratio of the mean change in score after treatment to the variability in patients at baseline. 23, 29, 30 This produces an ES, which allows the comparison of different instruments. We also calculated the standardized response mean (SRM), which is the change in mean scores over the SD of the change. 31 For both statistics, a value of 0.5 to 0.7 is considered moderate responsiveness, 0.80 to 1.0 is considered good, and greater than 1.0 is considered excellent. 32 Finally, because the Zung contained somatic items, we repeated the ES calculation for this inventory after excluding the items on sleep difficulties, appetite, libido, weight loss, constipation, heart racing, fatigue, early waking, and keeping up levels of activity (exclusion of 13 items). The responsiveness indicators for the remaining scores dropped from 0.9 to 0.02, indicating that the reported change postintervention was due almost entirely to change in somatic symptoms.
Construct Validity
Construct validity was tested by computing correlations for the subgroup of 82 patients pretreatment as presented in Table 3 (Pearson distributions were normal and Spearman r as a nonparametric alternative). A priori hypotheses included the prediction of strong and significant relationships between scores on the DAPOS-D against Zung Depression (positive correlation), SF-36 Role Limitations due to Emotional Problems, and SF-36 Mental Health (negative correlation, as lower scores on these SF-36 scales are indicative of worse functioning or more impact); DAPOS-A with catastrophizing, as measured by the PCS (positive correlation); and DAPOS-PO with SF-36 Vitality (positive correlation). As anxiety and depression are typically highly correlated, we expected to find similar relationships between the DAPOS-A and the SF-36 Role Limitations owing to Emotional Problems and Mental Health scales. The hypothesized relationships were confirmed in all cases ( Table 3 ). The DAPOS-D correlated (at P<0.01) with the Zung total score (r = 0.69), and the SF-36 Mental Health (r = À 0.5). The DAPOS-A correlated significantly (P<0.01) with the PCS (r = 0.55). The DAPOS-PO correlated significantly (P<0.01) with the SF-36 Vitality (r = 0.55). Several other significant relationships were also evident, notably between the DAPOS-D and the PCS (r = 0.48), and the DAPOS-A and the Zung (r = 0.51), reflecting the overlap between anxiety and depression.
Internal Consistency
The reliability of the 3 subscales of the DAPOS 9 as measured by the Cronbach a coefficient showed a reliability of 0.86 for the Depression subscale, of 0.90 for the Anxiety subscale, and of 0.74 for the Positive Outlook subscale, showing a good internal consistency for all the subscales of the questionnaire.
Confirmatory Factor Analysis
Twenty-one participants had missing values and were excluded from this section of the analysis. The confirmatory factor analysis was performed using data from 222 participants from the original pool. The questionnaire was tested as a single model with 3 latent factors (depression, anxiety, and positive outlook). Using maximum-likelihood estimation model, the estimates of fit indicated that the model tested presented a good fit, RMSEA = 0.044, CFI = 0.98, GFI = 0.95, and AGFI = 0.92. The model is shown in Figure 1 . In accordance with Hoyle and Panter, 33 standardized maximum-likelihood estimates of the variable parameters are reported. All questions load highly onto their respective latent variable, but also note that depression and anxiety are highly related to each other and both variables are very negatively related to positive outlook.
DISCUSSION
The study aimed to further develop and test the DAPOS questionnaire, and for the first time examined the responsiveness of the subscales to a pain management program aimed at rehabilitation by increasing activity and promoting return to work. In addition, we tested construct validity by posing a priori relationships between the DAPOS subscales and theoretically related measures. The construct validity of the DAPOS seems to be excellent. Internal consistency was demonstrated by highly acceptable a scores for all 3 subscales, and the internal structure of the questionnaire was confirmed with robust goodness of fit indicators.
Although anxiety and depression in pain have a long research history, positive outlook represents a relatively new, but promising area, which focuses on emotional well-being and pleasure. 34, 35 It is interesting that although the ES for the reduction of negative mood in this study were only moderate, the positive outlook scale showed good responsiveness, indicating that positive outlook improved considerably with treatment. However, more research is needed to understand the nature and characteristics of positive outlook in the context of chronic pain.
The DAPOS depression and anxiety subscales' responsiveness, although acceptable, were not as high as the responsiveness demonstrated by related measurements such as the Zung and the PCS in our sample. Nonetheless, the levels are comparable, if not better, than those published for other related measurements, such as the Fear Avoidance Beliefs Questionnaire. 36 Changes in the DAPOS-D and DAPOS-A scores were statistically significant, despite the fact that the intervention did not target mood as a primary area for change. In part, this could explain the high responsiveness demonstrated by the Tampa Scale of Kinesiophobia (TSK), because the messages delivered throughout the intervention matched beliefs expressed in this questionnaire. Applied to our results this might mean that even though the program has brought about changes in the way the majority of patients behave (in terms of walking and standing), and their ability to control their pain (as expressed in the PSEQ), it did not change patients' affect.
The relatively small changes in negative affect posttreatment might reflect poor responsiveness, or may reflect a drawback to this type of reactivating group intervention, in which the opportunity and time to address deep seated maladjusted cognitions and selfschema are seldom available. In consequence, it has been argued that in patients with clinical levels of depression, treatment modalities specifically targeting depressive symptoms deserve serious consideration as an integral component of pain management programs. 37, 38 The high responsiveness of the Zung, in contrast to both the DAPOS-D and the SF-36 Mental Health scales is most likely a reflection of the somatic items included in it. The inclusion of such items, which may reflect levels of pain, disability, or physical health in general contaminate the depression scale. 2, 17 The change in the somatic items postintervention might reflect change in levels of activity and fitness, but should be studied further, as these were not a direct target for this program.
The Positive Outlook scale of the DAPOS demonstrated independence from both anxiety and depression, and had the highest responsiveness scores. Our results suggest that depression (negative affect) is inversely correlated with positive outlook (positive affect) and are consistent with earlier studies. 9, 39, 40 However, recent models of affect suggest an orthogonal and dynamic relationship between positive and negative affect, and highlight individual differences in the ability to sustain affective differentiation (presence of positive and negative affect in the same situation) during pain. 41 Future research should examine how the relationship between positive and negative affect, measured by the DAPOS, varies both between individuals and within individuals over time. Moreover, the role of positive well-being and outlook should be extended in future research in relation to interventions and their outcomes.
Finally, on the basis of the current ES (B0.5), we recommend that the sample size required to demonstrate change in the DAPOS in independent groups is around 68/group, whereas that required for related group designs is around 34. 23 The current study has several limitations. First, all patients took part in a pain management program; therefore, results should not be generalized to individuals who do not seek treatment. Keeping in mind that the cutoff points to describe ES are somewhat arbitrary, the DAPOS showed good responsiveness and construct validity, suggesting that it may be appropriate for use in clinical trials or treatment evaluations. At the moment no normative data exist for comparison, which would be very useful for routine clinical use. Further study will be necessary to establish the clinical utility of the DAPOS. In particular, it would be helpful to continue the process of validation by comparing the DAPOS subscales with additional criterion variables. Especially in case of the DAPOS Positive Outlook scale, further research should deploy other measures of positive affect [eg, The Positive and Negative Affect Schedule (PANAS 42 ) ]. Finally, the DAPOS-A subscale performed less well than the other subscales and the reasons for this and possible improvements require further investigation. The inclusion of a general anxiety measure might be useful to further validate this subscale.
The DAPOS is potentially an extremely useful tool for researching affect in pain populations. This is because it has been carefully developed to exclude somatic items, it is short, has shown excellent validity and reliability, and includes the only subscale of positive outlook for pain populations. To be clinically useful, it will be necessary to publish comparative and normative data. Additionally, the DAPOS may be useful in other research and clinical applications, such as studies of patient classification and empirical subgroups, or studies of possible predictors of treatment outcome. Finally, we urge researchers to consider the study of responsiveness within the context of each intervention, its components, and the targeted outcomes. Thus, future studies should test the responsiveness of the DAPOS in different settings and with different diagnoses, and especially in interventions that target negative affect.
